{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:34:26Z","timestamp":1771054466129,"version":"3.50.1"},"reference-count":42,"publisher":"Baishideng Publishing Group Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCC"],"published-print":{"date-parts":[[2013]]},"DOI":"10.12998\/wjcc.v1.i2.74","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T08:36:59Z","timestamp":1368693419000},"page":"74","source":"Crossref","is-referenced-by-count":23,"title":["Biological therapy for dermatological manifestations of inflammatory bowel disease"],"prefix":"10.12998","volume":"1","author":[{"given":"Maddalena","family":"Zippi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03756.x"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02055.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh483"},{"key":"ref4","unstructured":"Andrisani G, Guidi L, Papa A, Armuzzi A. Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2012;16:890-901."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/07853890903559724"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Freeman HJ. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn’s disease. Can J Gastroenterol 2005;19:603-606.","DOI":"10.1155\/2005\/323914"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00504.x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.meg.0000243883.47938.aa"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199607000-00009"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200308000-00013"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01893.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Rosen T, Martinelli P. Erythema nodosum associated with infliximab therapy. Dermatol Online J 2008;14:3.","DOI":"10.5070\/D39XC3222X"},{"key":"ref13","unstructured":"Evans PE, Pardi DS. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. MedGenMed 2007;9:55."},{"key":"ref14","unstructured":"Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (NY) 2011;7:235-241."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.3780040209"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800780613"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20196"},{"key":"ref18","unstructured":"Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 2001;137:930-933."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000042245.20042.4f"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.074815"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2293"},{"key":"ref22","unstructured":"Fonder MA, Cummins DL, Ehst BD, Anhalt GJ, Meyerle JH. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 2006;5:e8."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0777"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0733-8"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.540"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005;11:7227-7236.","DOI":"10.3748\/wjg.v11.i46.7227"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1982.tb01731.x"},{"key":"ref28","unstructured":"Georgiou S, Pasmatzi E, Monastirli A, Tsambaos D. Cutaneous manifestations of inflammatory bowel disease. Hosp Chron 2006;1:158-168."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.021"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"ref31","unstructured":"Pitarch G, Sanchez-Carazo JL, Mahiques L, Perez-Ferriols MA, Fortea JM. Treatment of psoriasis with adalimumab. Clin Exp Dermatol 2007;32:18-22."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03955.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1586\/egh.12.64"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.10.007"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.125"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Eriksen KW, Lovato P, Skov L, Krejsgaard T, Kaltoft K, Geisler C, Ødum N. Increased sensitivity to interferon-alpha in psoriatic T cells. J Invest Dermatol 2005;125:936-944.","DOI":"10.1111\/j.0022-202X.2005.23864.x"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408506102"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.53.37957"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.07.022"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-28032012000200014"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.08.007"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.2.223"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T05:15:48Z","timestamp":1645074948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2307-8960\/full\/v1\/i2\/74.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v1.i2.74","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}